Quotient Therapeutics
Quotient Therapeutics is a biotechnology startup that develops medicines based on somatic genomics insights. The company raised $50M in seed funding in November 2023 and employs 76 people.
The growth story
Quotient Therapeutics grew from 2 to 76 employees between 2021 and 2026, raising $50M along the way, most recently a Seed in November 2023.
About
Quotient Therapeutics uses somatic genomics data to identify and develop potential new medicines. The company focuses on translating genomic insights into therapeutic candidates for various diseases.
The company was founded in 2022 and is backed by Flagship Pioneering, which led its $50M seed round. With 76 employees, Quotient Therapeutics is building its research capabilities in Cambridge, Massachusetts.
Founders and leadership
Quotient Therapeutics is primarily a research-focused organization, with 31 employees dedicated to research functions. The company is led by a team with strong ties to Flagship Pioneering and operates from its headquarters in Cambridge.
The Quotient Therapeutics org chart
Geoffrey von Maltzahn (Founding CEO, Chair) leads 30 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 42 (-2% YoY), Business Development 13 (+18% YoY), Engineering 7 (+40% YoY), Operations 3 (0% YoY).
Talent flow
Quotient Therapeutics draws talent from prominent institutions like the Wellcome Sanger Institute, GSK, and the University of Cambridge. Alumni have moved to companies such as AstraZeneca, Pfizer, and Takeda, indicating a strong connection to the pharmaceutical industry.
Most common previous employers of Quotient Therapeutics staff: Wellcome Sanger Institute (10), GSK (6), University of Cambridge (6), Tome Biosciences (4), UCL (4), AstraZeneca (4). Former Quotient Therapeutics employees most often moved to AstraZeneca (3), Pfizer (1), Flagship Pioneering (1), Takeda (1), Squarepoint (1), MapLight Therapeutics (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Quotient Therapeutics: Molecular Biology (33), Polymerase Chain Reaction (PCR) (32), Cell Culture (29), Research Skills (27), Communication (23), Genomics (23), Project Management (23), Bioinformatics (23).
Where the team actually sits
Quotient Therapeutics people are concentrated in England, United Kingdom (28), Massachusetts, United States (17), United Kingdom (9), Greater Boston (8).
Search footprint
Quotient Therapeutics attracts about 118 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 20 ranking keywords and lost 6 in the last period.
What employees say
- Compensation
- 5.00 / 5
- Career opportunities
- 3.00 / 5
- Senior management
- 2.00 / 5
- Work-life balance
- 4.00 / 5
Frequently asked
Quotient Therapeutics has 76 employees as of September 2026.
Quotient Therapeutics has raised $50M in total, most recently a Seed round in November 2023.
Quotient Therapeutics was founded in 2022 by Simon Brunner, Peter Campbell, Ph.D..
Geoffrey von Maltzahn (Founding CEO, Chair) sits at the top of Quotient Therapeutics's reporting structure, with 5 direct reports.
The most common previous employers of current Quotient Therapeutics staff are Wellcome Sanger Institute (10 people), GSK (6 people), University of Cambridge (6 people).
Former Quotient Therapeutics employees most often move to AstraZeneca (3), Pfizer (1), Flagship Pioneering (1).
Quotient Therapeutics attracts about 118 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Quotient Therapeutics staff are Molecular Biology, Polymerase Chain Reaction (PCR), Cell Culture, Research Skills, Communication.
Quotient Therapeutics staff are concentrated in England, United Kingdom (28), Massachusetts, United States (17), United Kingdom (9).
Quotient Therapeutics has about 42 people in Research, down 2% over the past year, as of September 2026.
Quotient Therapeutics has about 13 people in Business Development, up 18% over the past year, as of September 2026.
Computed from 65 current and 31 former Quotient Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.